Pyxis Oncology is trading 5% up today at $3.32, extending a sharp multi-session rebound following a recent $50 million private placement.
- The financing deal, which included attached warrants, has significantly expanded the company's funding runway and drew supportive commentary from analysts.
- Today's price action represents a continuation of recent momentum, further bolstered by a firmer overall biotech tape.